Navigation Links
TGen finds protein inhibitor revives chemotherapy for ovarian patients
Date:7/6/2010

PHOENIX, Ariz. July 6, 2010 Investigators at the Translational Genomics Research Institute (TGen) have discovered a way that may help ovarian cancer patients who no longer respond to conventional chemotherapy.

A scientific paper that will be published in the September issue of the journal Gynecologic Oncology describes how the inhibition of a protein, CHEK1, may be an effective element to incorporate into therapies for women with ovarian cancer.

The research led by TGen's Dr. David Azorsa, a Senior Investigator, and Dr. Shilpi Arora, a Staff Scientist, found that inhibiting CHEK1 by a small molecule known as PD 407824, enabled ovarian cancer cells to be attacked again by cisplatin, a widely used platinum-based chemotherapy drug for women with ovarian cancer.

"PD 407824 is only available for laboratory research, but other drugs inhibiting CHEK1 are already used to treat patients in the clinic," said Dr. Raoul Tibes, one of the paper's senior a co-authors and an Associate Investigator in TGen's Clinical Translational Research Division.

The prognosis remains poor for patients with ovarian cancer, which kills nearly 14,600 women in the U.S. annually. The standard treatment for cancer of the ovaries, which produce human egg cells, is surgical removal of the cancer, followed by chemotherapy.

The TGen team proved their method in the research laboratory, which is very encouraging, considering that the use of protein inhibitors in combination with cisplatin, is also proving to be effective in clinical trials with cancer patients.

"The clinical relevance is high, as such novel molecular concepts inhibiting the repair of cancer cells after treatment with chemotherapies are in development for many different cancers," said Dr. Tibes, a medical oncologist who treats patients with advanced cancers at TGen Clinical Research Services (TCRS) at Scottsdale Healthcare.

"We actually have similar drug combi
'/>"/>

Contact: Steve Yozwiak
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related biology news :

1. Terrorist de-radicalization shows promise, comprehensive study finds
2. Air pollution doesnt increase risk of preeclampsia, early delivery, study finds
3. Study finds that simple 2-question survey can better identify hungry children
4. Messenger RNAs are regulated in far more ways than previously appreciated, CSHL team finds
5. Organic pesticides not always greener choice, study finds
6. NIH-supported study finds novel pathway may open doors for new blood pressure treatments
7. Large majority of Americans still believe in global warming, Stanford poll finds
8. Study finds epigenetic similarities between Wilms tumor cells and normal kidney stem cells
9. UM School of Medicine study finds vaginal microbes vary among healthy women
10. Neural tissue contains imbalanced levels of proteins, U-M study finds
11. Jumping genes provide extensive raw material for evolution, Penn study finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... USA New Geology articles posted ... 2013 cover a wide swath of geoscience subdisciplines, ... geophysics, and paleobotany. Locations studied include Siberia; the ... Alpi Apuane, Italy; Ukraine; Mars; and the Southeastern ... 1. Rubies, jadeite, and plate tectonics;, 2. The ...
(Date:5/18/2013)... 18, 2013) Research presented today at Digestive Disease ... with findings about the impact of coffee on autoimmune ... While coffee consumption recently has been associated with reduced ... a few more cups of java each month also ... disease. Researchers at the Mayo Clinic, Rochester, MN, linked ...
(Date:5/17/2013)... at Rutgers, The State University of New Jersey, and ... new formulation called Visikol TM that effectively clears ... used in place of chloral hydrate, which is one ... which is tightly regulated by the Drug Enforcement Administration ... Clearing solutions, or clearing agents, are vital for viewing ...
Breaking Biology News(10 mins):New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 2New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 3New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 4New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 5New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 6New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 7New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 8New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 9New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 10New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 11Coffee consumption associated with reduced risk of autoimmune liver disease 2New formula invented for microscope viewing, substitutes for federally controlled drug 2New formula invented for microscope viewing, substitutes for federally controlled drug 3
... that is innate in human beings. This means laughing at ... the fear of being laughed at causes some people enormous ... a disorder that affects people in all cultures alike. ... who suffers from gelotophobia? One of the aims of a ...
... Protection Agency (EPA) will celebrate its 40th birthday in ... A group of nationally recognized experts in environmental science, ... a more integrated approach to environmental protection that accounts ... In an article to be published in the December ...
... assumed that animals and plants developed different genetic programs ... teams, including one at the Swedish University of Agricultural ... that determine programmed cell death in plants and animals ... similar way. The findings were published in Nature ...
Cached Biology News:Fear of being laughed at crosses cultural boundaries 2Fear of being laughed at crosses cultural boundaries 3Fear of being laughed at crosses cultural boundaries 4Cell death occurs in the same way in plants, animals and humans 2
(Date:5/21/2013)... , May 21, 2013 ... Market Research ( http://www.transparencymarketresearch.com ) "Biochip Products and Services ... Tests) - U.S. Industry Analysis, Size, Share, Growth, Trends and Forecast, ... in 2011 and is expected to grow at a ... an estimated value of USD 4.7 billion in 2018. ...
(Date:5/21/2013)... 21, 2013  MacroGenics, Inc. today announced that ... (MGAH22), an Fc-modified chimeric monoclonal antibody (MAb), in ... oncoprotein," will be presented at the 2013 Annual ... during the Developmental Therapeutics - Immunotherapy Oral Abstract ... 4:30 PM.  The presentation will describe the results ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Revolutionary Science, ... automatic colony counter, announced today that they have expanded ... products , the IncuCount, IntelliCount, InCount and ImpressCount. ... sophistication are especially useful in food microbiology and pharmaceutical ... an updated look. A bright white enclosure with ...
(Date:5/21/2013)... May 21, 2013 Possible mold re-infestation in ... according to a report from eagletribune.com posted May 14, 2013, ... case the result is positive, My Cleaning Products offered a ... chemical ingredients. , It was said in the Eagle Tribune ... in the campus sparked after a first-grade classroom was closed ...
Breaking Biology Technology:The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 2The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 4The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 5MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3Revolutionary Science Announces New Automatic and Manual Colony Counting Products 2Possible Mold Re-infestation Gets Guilmette School Scheduled for Re-inspection, My Cleaning Products Offers Tip How to Kill Mold Safely If Inspection Turns Positive 2Possible Mold Re-infestation Gets Guilmette School Scheduled for Re-inspection, My Cleaning Products Offers Tip How to Kill Mold Safely If Inspection Turns Positive 3
... Company’s Global R&D Headquarters in Wilmington. , ... ... and Delaware government leaders today unveiled their $80 million Innovation ... technology capabilities in Delaware. The partnership includes opening of ...
... New Jersey, October 23, Rosetta Genomics Ltd. (Nasdaq: ... diagnostics and therapeutics, today,announced that it will present ... in Cancer". The event will take place from,October ... The poster presentation, titled "MicroRNA-based identification of tumor,origin", ...
... April 27, 2009 to Regain Compliance with $1.00 ... Minimum Bid ... (Nasdaq: PPHM ), a clinical stage biopharmaceutical,company developing monoclonal antibodies ... it has received a letter,from NASDAQ that provides Peregrine with additional ...
Cached Biology Technology:DuPont and State of Delaware Unveil $80 Million Innovation Center Partnership 2DuPont and State of Delaware Unveil $80 Million Innovation Center Partnership 3DuPont and State of Delaware Unveil $80 Million Innovation Center Partnership 4DuPont and State of Delaware Unveil $80 Million Innovation Center Partnership 5Rosetta Genomics to Present at the Upcoming EORTC-NCI-ASCO Annual Meeting on "Molecular Markers in Cancer" 2Rosetta Genomics to Present at the Upcoming EORTC-NCI-ASCO Annual Meeting on "Molecular Markers in Cancer" 3Peregrine Pharmaceuticals Receives Additional Time to Regain Compliance With NASDAQ's Minimum Bid Price Rule 2
ssDNA from PCR DNA in less than 1 hour. No gels, columns, or slurries. Sequence from high quality ssDNA: clearer reads, longer runs....
... of Freezerworks Unlimited includes 2 clients and streamlines ... the sharing of freezers by multiple groups without ... Network Client/Server version for ... monitor with 256 colors; OS 8.6 & OS ...
Applications: Immunohistochemistry, ISH, FISH, CISH....
... Amplification Kit, 500 reactions. Prepare circular ... 4-6 h.Generate microgram quantities of template ... material.Use amplified DNA directly for cycle ... or M13 liquid cultures, colonies, plaques, ...
Biology Products: